In the pharmaceutical world, there’s a huge competition to beat Novo Nordisk and Eli Lilly’s popular obesity medications. Many companies […]
Thorsten Stafforst recalls being discouraged from pursuing RNA editing research a decade ago when CRISPR, a new tool for altering
Here’s a simplified version of the text: There have been some important updates from major biotech companies like Biogen and
GSK, a large pharmaceutical company, is spending $300 million to buy a new type of drug from Chimagen Biosciences, a
Pfizer recently announced strong earnings for the third quarter, surpassing Wall Street expectations, and has increased its revenue forecast for
The U.K. government and its drug regulator have warned against the misuse of certain weight-loss medications by people who don’t
Pfizer and the American Cancer Society (ACS) have teamed up with actor Patrick Dempsey to raise awareness about the challenges
Parabilis Medicines, formerly known as FogPharma, has rebranded to emphasize its goal of making significant advancements in treating serious diseases
Novartis and Apellis Pharmaceuticals are competing to develop treatments for a rare kidney disease. Both companies have shared promising data
As the global population continues to age, the search for effective interventions to combat the challenges of aging has become